Clik here to view.
SCIEX Sponsored Award Recognizes Notable Contributions to Electrodriven...
FRAMINGHAM, Mass. SCIEX, a global leader in life science analytical technologies, has announced that the MSB Strategic Planning Committee has selected Dr. Shigeru Terabe, Professor Emeritus of the...
View ArticleClik here to view.
世界首创基于基因组的共享型经济平台‘MGB(mygenomebox),’ 利用DNA App在CES Asia 2017运营全新生活体验区
首尔 (美国商业资讯)– 基于基因组的共享型经济平台MGB(mygenomebox)参展“CES Asia 2017”敲响了其进入亚洲市场的钟声。 今年的CES ASIA在中国上海新国际博览中心(SNIEC)召开，展期从6月7日起到9日，将展出包括美国、中国在内的世界最大市场及亚洲各国最新家电产品市场走向和产品。 MGB曾于今年1月参加在拉斯维加斯举办的世界国际电子产品博览会(Consumer...
View ArticleClik here to view.
Takeda and Seattle Genetics Announce Lancet Publication of Phase 3 ALCANZA...
CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash. Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the randomized...
View ArticleClik here to view.
Exelixis Announces Initiation of Phase 1b Trial of Cabozantinib in...
SOUTH SAN FRANCISCO, Calif. Exelixis, Inc. (NASDAQ:EXEL) today announced the initiation of the dose-escalation stage of a phase 1b trial of cabozantinib in combination with atezolizumab (TECENTRIQ®)...
View ArticleClik here to view.
Humacyte® Selected as 2017 Technology Pioneer by World Economic Forum
RESEARCH TRIANGLE PARK, N.C. Humacyte, an innovator in biotechnology and regenerative medicine, was selected among hundreds of candidates as one of the World Economic Forum’s 30 “Technology...
View ArticleClik here to view.
Intensity Therapeutics Issued New Patents for Technology Platform
WESTPORT, Conn. Intensity Therapeutics, Inc., a privately held clinical-stage, biotechnology company developing proprietary cancer immunotherapy products, today announced that the United States...
View ArticleClik here to view.
Takeda and Seattle Genetics Announce Positive Results from Phase 3 ECHELON-1...
CAMBRIDGE, Mass., OSAKA, Japan & BOTHELL, Wash. Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that the Phase 3 ECHELON-1 clinical...
View ArticleClik here to view.
Eloxx Pharmaceuticals Receives a US$6 Million Investment from KIP and DCS to...
SAN DIEGO & REHOVOT, Israel & SEOUL, South Korea Today, Korea Investment Partners (KIP), DSC Investments, Sevion Therapeutics, Inc. (OTCQB:SVON) and Eloxx Pharmaceuticals Ltd, a clinical...
View ArticleClik here to view.
Groundbreaking Multi-Center Clinical Trial Confirms Low-Dose Aspirin Therapy...
LJUBLJANA, Slovenia PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the publication of the Fetal Medicine Foundation’s (FMF’s) Project “ASPRE” study...
View ArticleClik here to view.
The New SCIEX Clinical AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS System Obtains...
SHANGHAI SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that the AB SCIEX TRIPLE QUAD™ 4500MD...
View ArticleClik here to view.
武田薬品とシアトル・ジェネティクスが進行期ホジキンリンパ腫のフロントライン治療でアドセトリス（ブレンツキシマブ・ベドチン）を評価する第3相ECHELON-...
米マサチューセッツ州ケンブリッジ & 大阪 & 米ワシントン州ボセル （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:4502）とシアトル・ジェネティクス（NASDAQ:...
View ArticleClik here to view.
武田与Seattle Genetics发布ADCETRIS® (brentuximab...
马萨诸塞州剑桥、日本大阪和华盛顿州博瑟尔 (美国商业资讯) — 武田药品工业株式会社(TSE:4502)和Seattle Genetics, Inc. (NASDAQ: SGEN)今天宣布，3期ECHELON-1临床试验达到主要终点，即修订版无进展生存(PFS)优于对照组，差异有统计学意义。ECHELON-1是随机、多中心试验，评估ADCETRIS (brentuximab...
View ArticleClik here to view.
Prana’s PBT434 Lowers Alpha-Synuclein and Prevents Neurodegeneration
MELBOURNE, Australia & SAN FRANCISCO Prana Biotechnology Ltd (NASDAQ: PRAN) (ASX: PBT) today announced the article “The novel compound PBT434 prevents iron-mediated neurodegeneration and...
View ArticleClik here to view.
Konica Minolta to Acquire U.S.-based Ambry Genetics in a Deal Valued at US$1...
TOKYO & ALISO VIEJO, Calif. Konica Minolta, Inc. (Konica Minolta) (TOKYO: 4902) (ISIN: JP3300600008) and Ambry Genetics Corporation (Ambry) today announced the signing of a definitive agreement...
View ArticleClik here to view.
Octapharma将在即将于德国柏林召开的2017年ISTH大会上赞助多项重要活动
瑞士拉亨 (美国商业资讯) — Octapharma今天宣布，该公司将在今年的国际血栓和瘀血学会(ISTH)大会上积极参与广泛的活动。此次大会将于7月8–13日在德国柏林召开。Octapharma很高兴成为此次大会的铂金制造商，体现了推动血友病和von Willebrand病(VWD)患者治疗的不懈承诺。...
View ArticleClik here to view.
オクタファルマの活動、独ベルリンでの来る2017年ISTH総会で際立つ
スイス・ラッヘン （ビジネスワイヤ） — オクタファルマは本日、今年の国際血栓止血学会（ISTH）総会で多様な活動に積極参加すると発表しました。総会はドイツのベルリンで7月8～13日に開催されます。オクタファルマは光栄にも総会のプラチナスポンサーですが、これは血友病とフォン・ヴィルブランド病（VWD）の患者の治療を前進させるために一貫して傾倒していることを反映するものです。...
View ArticleClik here to view.
Counsyl and Angsana Bring Expanded Carrier Screening to Clinicians and...
SOUTH SAN FRANCISCO, Calif. & SINGAPORE Counsyl, a DNA testing and genetic counseling service, today announced an expanded agreement with Angsana Molecular & Diagnostics Laboratory, a...
View ArticleClik here to view.
ImmunArray Enters Partnership with Kindstar Global
RICHMOND, Va. ImmunArray, a privately held molecular device company dedicated to the development of novel, blood-based in vitro diagnostic tests, and Kindstar Global Co., Ltd., a specialty clinical...
View ArticleClik here to view.
麻省理工学院和哈佛大学旗下博德研究所等机构加入MPEG LA的CRISPR-Cas9联合授权推广项目
丹佛 (美国商业资讯)–全球授权领军企业MPEG LA, LLC欣然宣布，主要的CRISPR专利所有者已提交专利，以响应MPEG LA参加打造国际化CRISPR-Cas9联合授权平台的呼吁。同时，MPEG LA, LLC仍将继续接受专利提交。 MPEG LA总裁兼首席执行官Larry Horn表示，“对MPEG...
View ArticleClik here to view.